Noninvasive prenatal screening (NIPS) tests have emerged as a popular tool for pregnant individuals seeking reassurance about their baby’s health. Offered during the first trimester, these tests analyze a small sample of the mother’s blood to assess the risk of chromosomal abnormalities, including Down syndrome. While intended to provide peace of mind, increasing scrutiny surrounding